Protinhi Therapeutics raised funding form the European Innovation Council

The Netherlands Enterpise Agency (RVO) highlighted 11 Dutch start-ups have raised a total of €77 million in funding from the European Innovation Council (EIC) Accelerator programme. This puts the Netherlands in second place among the countries that receive the most money from this programme.

One of those companies is Nijmegen-based Prothinhi Therepeutics, a preclinical stage biotech company developing novel broad-spectrum antiviral drugs against upcoming viral health threats diseases (dengue, zika, WNV, Corona, Chikungunia) with a high unmet medical need.